STOCK TITAN

Haemonetics To Present At The 19th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

BOSTON, Aug. 25, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 19th Annual Morgan Stanley Virtual Global Healthcare Conference on Thursday, September 9, 2021, at 8:45 a.m. ET.

The public may access Mr. Simon's presentation live via webcast and subsequent replay at: https://morganstanley.webcasts.com/viewer/event.jsp?ei=1488538&tp_key=5d97833d77

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contact       

Media Contact

Olga Guyette, Director-Investor Relations 

Josh Gitelson, Director-Global Communications

(781) 356-9763      

(781) 356-9776

olga.guyette@haemonetics.com  

josh.gitelson@haemonetics.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-19th-annual-morgan-stanley-global-healthcare-conference-301362655.html

SOURCE Haemonetics Corporation

Haemonetics Corp.

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Stock Data

Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Health Technology, Medical Specialties, Manufacturing, Surgical and Medical Instrument Manufacturing
US
Boston

About HAE

haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn’t need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right